Charles River Associates beat Q2 earnings and revenue estimates on broad-based growth, while raising its fiscal 2026 revenue outlook to $805-$820 million.
CRA International, Inc. (CRAI) Q2 2026 Earnings Call Transcript
CRA International (CRAI) came out with quarterly earnings of $2.16 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $1.88 per share a year ago.
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced financial results for the fisc
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced an increase and extension to
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial and management consulting services, today announced that its Board of Directors ha
Charles River Associates (NASDAQ: CRAI - Get Free Report)'s stock price gapped down prior to trading on Friday. The stock had previously closed at $167.32, but opened at $150.13. Charles River Associa
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced that the company will webcast
BOSTON--(BUSINESS WIRE)--Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, today announced the addition of Kevin William
Investors need to pay close attention to CRAI stock based on the movements in the options market lately.
Charles River Associates' global talent network, cross-border expertise, and rising dividends and buybacks support long-term growth and enhance investor appeal.
PHILADELPHIA and VANCOUVER, British Columbia, July 07, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage bio
CRAI benefits from rising demand for specialized advisory services, but AI, talent costs and fierce competition pose risks.
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Rising talent costs, persistent inflation and cautious corporate spending are weighing on the consulting services industry. Expert consultation and data-driven advisory demand are likely to aid.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE